Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.30
-0.11 (-2.03%)
At close: Apr 28, 2026, 4:00 PM EDT
5.50
+0.20 (3.77%)
Pre-market: Apr 29, 2026, 4:09 AM EDT
Zura Bio Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Zura Bio stock have an average target of 13, with a low estimate of 2.00 and a high estimate of 18. The average target predicts an increase of 145.28% from the current stock price of 5.30.
Analyst Consensus: Buy
* Price targets were last updated on Mar 23, 2026.
Analyst Ratings
The average analyst rating for Zura Bio stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +107.55% | Mar 23, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +183.02% | Mar 20, 2026 |
| Wedbush | Wedbush | Buy Initiates $15 | Buy | Initiates | $15 | +183.02% | Feb 9, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +88.68% | Nov 14, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +239.62% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.75M
EPS This Year
-0.68
from -1.06
EPS Next Year
-0.63
from -0.68
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 78.8M | ||||||
| Avg | n/a | 12.8M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.49 | -0.12 | |||
| Avg | -0.68 | -0.63 | |||
| Low | -0.87 | -1.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.